Earnings NewsKnight Therapeutics reports Q3 resultsNov. 12, 2019 5:27 PM ETKnight Therapeutics Inc. (KHTRF) Stock, GUD:CA StockKHTRFBy: Pranav Ghumatkar, SA News Editor Knight Therapeutics (OTC:KHTRF): Q3 GAAP EPS of -C$0.021. Revenue of C$4.03M (+25.2% Y/Y) Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgKHTRFKHTRF--GUD:CAGUD:CA--1D5D1M6M1Y5Y10YCompareTrending AnalysisTrending News